1. Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018
2. How patient cost‐sharing trends affect adherence and outcomes: a literature review;Eaddy MT;P T,2012
3. Centers for Disease Control and Prevention.Data Brief 317.High‐Deductible Health Plan Enrollment Among Adults Aged 18‐64 With Employment‐based Insurance Coverage.Atlanta GA:Centers for Disease Control and Prevention.https://www.cdc.gov/nchs/data/databriefs/db317_table.pdf. Accessed October 25 2020.
4. Medicaid drug rebate program.Centers for Medicare and Medicaid Services website.https://www.medicaid.gov/medicaid/prescription‐drugs/medicaid‐drug‐rebate‐program/index.html. Last updated January 22 2021. Accessed June 1 2020.
5. BachP.Zolgensma: a remarkable new treatment an ICER analysis and a poorly justified price.Health Affairs Blog. June 18 2019.https://www.healthaffairs.org/do/10.1377/hblog20190617.50453/full/. Accessed June 1 2020.